The short-seller’s report arrived on the same day ASP Isotopes announced the completion of a Silicon-28 enrichment facility in Pretoria.
Analysts expect Dell to benefit from the increased buzz around AI, but Morgan Stanley warns there may be limited upside to estimates.
Net sales decreased 8.8% year-over-year (YoY) to $3.5 billion, missing an analyst estimate of $3.65 billion.
The "Detroit Big Three" rely on highly integrated North American supply chains.
Total revenue rose 10.5% year-over-year (YoY) to $2.53 billion during the quarter, but fell short of a Wall Street estimate of $2.55 billion.
CrowdStrike is widely expected to report roughly flat earnings per share performance despite robust revenue growth.
The company raised its full year guidance for comparable sales growth to a range of 3.6% to 4.2%, up from 2.5% to 3.5% previously.
The news comes just a day after TOYO disclosed plans to acquire 100% membership interests in Solar Plus Technology Texas.
The deal underscores Roche's interest in Poseida’s proprietary non-viral platform, which enables the development of allogeneic CAR-T therapies enriched with T stem cell memory cells.
Citi reportedly noted that Chevron stock trades at a discount versus its peers and this has created an attractive entry point.
